Dr. Petrovic is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4800 Sand Point Way NE
Seattle, WA 98105Phone+1 206-987-7450Fax+1 206-987-3830
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 2000 - 2003
- New York Presbyterian Hospital (Cornell Campus)Residency, Pediatrics, 1997 - 2000
- Oregon Health and Science University School of MedicineClass of 1997
Certifications & Licensure
- WA State Medical License 2016 - 2025
- AK State Medical License 2021 - 2024
- ID State Medical License 2021 - 2023
- MT State Medical License 2021 - 2023
- FL State Medical License 2003 - 2021
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Single vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501) Start of enrollment: 2006 Dec 01
- Stem Cell Related Donor Safety Study Start of enrollment: 2010 Jan 01
- A Study of Withdrawal of Immunosuppression and Donor Lymphocyte Infusions Following Allogeneic Transplant for Pediatric Hematologic Malignancies Start of enrollment: 2009 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 107 citationsPhase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD.Benjamin Watkins, Muna Qayed, Courtney McCracken, Brandi Bratrude, Kayla Betz
Journal of Clinical Oncology. 2021-01-15 - 21 citationsAbatacept for GVHD prophylaxis can reduce racial disparities by abrogating the impact of mismatching in unrelated donor stem cell transplantation.Muna Qayed, Ben Watkins, Scott Gillespie, Brandi Bratrude, Kayla Betz
Blood Advances. 2021-11-09 - 112 citationsSCID genotype and 6-month posttransplant CD4 count predict survival and immune recoveryElie Haddad, Brent R. Logan, Linda M. Griffith, Rebecca H. Buckley, Roberta E. Parrott
Blood. 2018-10-25
Press Mentions
- Using Gene Therapy to Build an Immune System in Newborns Without OneAugust 29th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: